China vs Kyrgyzstan: HIV-positive TB patients on ART (antiretroviral therapy)
China
85.0%
in 2024
Kyrgyzstan
85.0%
in 2024
China rank
106th
Kyrgyzstan rank
106th
HIV-positive TB patients on ART (antiretroviral therapy) over time
- China
- Kyrgyzstan
How they compare
China currently reports 85.0% against 85.0% in Kyrgyzstan, a difference of 0.0%.
The two have swapped places 5 times across 14 shared years of data; in 2009 it was China ahead.
China ranks 106th and Kyrgyzstan ranks 106th of 144 countries.
Across the 3 decades both report, China averaged higher in 2 and Kyrgyzstan in 1.
Head to head by decade
| Decade | China | Kyrgyzstan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 43.0% | 22.0% | 21.0% | China |
| 2010s | 63.0% | 68.0% | 5.0% | Kyrgyzstan |
| 2020s | 81.2% | 73.8% | 7.5% | China |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), China or Kyrgyzstan?
- China, at 85.0% against 85.0% in Kyrgyzstan as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between China and Kyrgyzstan?
- 0.0%, with China ahead.
- How many years of comparable data are there for China and Kyrgyzstan?
- 14 years are reported by both, from 2009 to 2024.
- How do China and Kyrgyzstan rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- China ranks 106th and Kyrgyzstan ranks 106th of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.